News from relmada therapeutics inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Feb 24, 2015, 08:00 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Novel Oral Formulations of Buprenorphine

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced...

Feb 09, 2015, 08:00 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics to Present at the 17th Annual BIO CEO & Investor Conference

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Feb 04, 2015, 08:00 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics Selects MepiGel Formulations to Advance Into Clinical Studies

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Jan 16, 2015, 08:30 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics to Present at 11th Annual Noble Financial Capital Markets Equity Conference

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Jan 13, 2015, 08:00 ET
Relmada Therapeutics Corporate Logo

Relmada Therapeutics Reaches Midway Point in Dose Escalation for Phase One Study of Novel NMDA Receptor Antagonist d-Methadone

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Jan 07, 2015, 08:30 ET

Relmada Therapeutics to Present at OneMedForum in San Francisco

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today...

Jan 06, 2015, 08:30 ET

Relmada Therapeutics to Provide Corporate Update at 2015 Biotech Showcase™ in San Francisco

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Dec 22, 2014, 08:30 ET

Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Dec 18, 2014, 16:35 ET

Relmada Therapeutics Announces Results of Annual Shareholders Meeting

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced the...

Dec 10, 2014, 08:30 ET

Relmada Therapeutics Appoints Christine Silverstein as Director of Investor Relations

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Dec 03, 2014, 08:00 ET

Relmada Therapeutics Nominated for Buzz of BIO Contest at the 2015 BIO CEO & Investor Conference

Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, is pleased to...

Dec 02, 2014, 08:30 ET

Relmada Therapeutics Receives Health Canada Clearance to Commence First Clinical Study of d-Methadone

Novel Product Virtually Devoid of Opioid Activity Being Studied in Neuropathic Pain. Relmada Therapeutics, Inc. (OTCQB: RLMD), a...

Nov 24, 2014, 08:30 ET

Relmada Therapeutics To Present At LD MICRO Conference

 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Nov 04, 2014, 08:00 ET

Relmada Therapeutics Appoints Michael Becker As Senior Vice President Of Finance And Corporate Development

 Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Oct 16, 2014, 08:00 ET

Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From Exercise Of Warrants

 Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Oct 02, 2014, 08:15 ET

Relmada Therapeutics Appoints Julie J. Chen As Director of Finance and Operations

 Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced...

Sep 18, 2014, 07:45 ET

Relmada Therapeutics, Inc. Appoints Christopher W. James As Senior Director of Clinical Development

Relmada Therapeutics, Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today...

Sep 16, 2014, 07:45 ET

Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER

 Relmada Therapeutics, Inc., (OTCBB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain,...

Sep 10, 2014, 08:00 ET

Relmada Announces The Filing Of Clinical Trial Application In Canada For d-methadone

Relmada Therapeutics, Inc. (OTCBB: RLMD) ("Relmada" or the "Company"), a clinical stage company developing novel therapies for the treatment of...

Sep 09, 2014, 08:15 ET

Relmada Therapeutics, Inc. Provides Its First Corporate Update as a Public Company

 Relmada Therapeutics, Inc., (OTCBB: RLMD), a Nevada corporation (the "Company") developing novel therapies for the treatment of chronic pain,...